Manager, Quality Services, External Manufacturing at Bristol-Myers Squibb

Dublin, County Dublin, Ireland

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • No explicit requirements listed in the job description

Responsibilities

  • Provide quality/compliance support to the Quality Operations
  • Co-ordinate/track the annual CMO Risk Assessment (RA), ensuring timely completion of the assessment
  • Support Quality Risk Mitigation Plans for CMOs based on the annual RA and any other interim triggers, and monitor their implementation
  • Write, revise and review GMP documentation where necessary
  • Prepare / negotiate Quality Agreements with the Third Party Manufacturers, Third Party Customers (TPCs), Alliance Partners and Marketing Authorisation Holders, including those associated with multiple CMOs / BMS parties
  • Support the Quality Operations metrics programs in relation to both Third Party and External Manufacturing performance
  • Support receipt of the Annual Product Quality Reviews (APQRs) from the Third Party Manufacturers and manage Quality Operations compliance with the APQR procedure
  • Work with BMS sites to ensure that APQRs are provided to TPCs and Alliance Partners in a timely manner
  • Support gap analysis of site SOPs / quality directives / policies / global Health Authority (HA) observations as the SME for Quality Operations and ensure gaps are mitigated
  • Where applicable lead/support the Quality Council activities
  • Provide general GMP / GDP HA inspection or Self Inspection support as required (preparation, back room, etc.)
  • Manage the quality oversight for TPCs / Alliance partners including change management, complaint management and investigation and CAPA management
  • Provide the requisite quality support to Global BMS functional groups such as Global Regulatory / CMC and the local country based regulatory managers in support of regulatory filings, product renewals, and regulatory agency questions etc. for CMOs
  • Represent ExM Quality on global quality teams/initiatives/projects

Skills

Quality Compliance
External Manufacturing
Contract Manufacturing Organizations
CMO Management
GMP
Supply Chain Management
Quality Assurance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI